Oragenics, Inc.
$0.58▼ 3.48%($-0.02)
TickerSpark Score
48/100
▌ Weak
90
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OGEN research report →
52-Week Range8% of range
Low
$0.50
Current
$0.58
High
$1.57
Company Overviewwww.oragenics.com
About the company
Oragenics, Inc. (OGEN) is a U. S.
- CEO
- Janet Huffman
- IPO
- 2004
- Employees
- 3
- HQ
- Tampa, FL, US
Price Chart
-59.38% · this period
Valuation
- Market Cap
- $2.64M
- P/E
- -0.10
- P/S
- 0.00
- P/B
- 0.41
- EV/EBITDA
- 0.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -177.32%
- ROIC
- -126.03%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-9,842,487 · 6.86%
- EPS
- $-4.56 · -185.00%
- Op Income
- $-9,362,503
- FCF YoY
- -107448.87%
Performance & Tape
- 52W High
- $1.57
- 52W Low
- $0.50
- 50D MA
- $0.60
- 200D MA
- $0.85
- Beta
- 1.25
- Avg Volume
- 53.34K
Get TickerSpark's AI analysis on OGEN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 12, 25 | Telling Fred | sell | 210 |
| Dec 11, 25 | Huffman Janet | other | 250,000 |
| Dec 11, 25 | Giordano Natasha | other | 125,000 |
| Dec 11, 25 | Giordano Natasha | other | 38,320 |
| Dec 11, 25 | Telling Fred | other | 125,000 |
| Dec 12, 25 | Telling Fred | sell | 210 |
| Dec 11, 25 | GANDOLFO JOHN P | other | 125,000 |
| Dec 11, 25 | DUNTON ALAN W | other | 125,000 |
| Dec 11, 25 | KOSKI ROBERT C | other | 125,000 |
| Dec 11, 25 | POPE CHARLES L | other | 125,000 |
Coverage · OGEN
Our OGEN coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on OGEN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OGEN report →Internal Compare
Similar companies
Peers in the same neighborhood.